Volume | 3 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
SELLAS Life Sciences Group Inc | SLS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.53 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
3 | 3 | - | 0.4986 - 1.914 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
06:14:03 | 1 | $ 1.52 | USD |
SELLAS Life Sciences Group Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
49.06M | 32.06M | - | 0 | -37.34M | -1.16 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
SELLAS Life Sciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.32 | 1.62 | 1.28 | 1.49 | 1,349,118 | 0.21 | 15.91% |
1 Month | 1.06 | 1.62 | 0.96 | 1.29 | 1,616,200 | 0.47 | 44.34% |
3 Months | 0.60 | 1.72 | 0.551 | 1.10 | 1,454,145 | 0.93 | 155.00% |
6 Months | 0.95 | 1.72 | 0.4986 | 0.9867956 | 1,169,709 | 0.58 | 61.05% |
1 Year | 1.40 | 1.914 | 0.4986 | 1.06 | 700,267 | 0.13 | 9.29% |
3 Years | 7.77 | 15.0789 | 0.4986 | 3.19 | 428,200 | -6.24 | -80.31% |
5 Years | 0.944 | 19.38 | 0.1021 | 1.95 | 2,391,409 | 0.586 | 62.08% |
SELLAS Life Sciences Description
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. |